98 related articles for article (PubMed ID: 19173993)
1. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
2. Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.
Rais G; Raissouni S; Aitelhaj M; Rais F; Naciri S; Khoyaali S; Abahssain H; Bensouda Y; Khannoussi B; Mrabti H; Errihani H
BMC Womens Health; 2012 Oct; 12():35. PubMed ID: 23039971
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma.
Wijesinghe HD; Wijesinghe GK; Mansoor Z; Vigneshwara S; Fernando J; Gunasekera D; Lokuhetty MDS
BMC Womens Health; 2020 Sep; 20(1):206. PubMed ID: 32928183
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status.
Amar S; McCullough AE; Tan W; Geiger XJ; Boughey JC; McNeil RB; Coppola KE; McLaughlin SA; Palmieri FM; Perez EA
Oncologist; 2010; 15(10):1043-9. PubMed ID: 20930097
[TBL] [Abstract][Full Text] [Related]
5. Are breast cancer molecular classes predictive of survival in patients with long follow-up?
Pracella D; Bonin S; Barbazza R; Sapino A; Castellano I; Sulfaro S; Stanta G
Dis Markers; 2013; 35(6):595-605. PubMed ID: 24288429
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone receptor status on patient clinic and survival in HER2 positive breast cancer.
Yılmaz M; Erdiş E; Uçar M; Demir N; Alandağ C; Yücel B
Jpn J Clin Oncol; 2024 May; 54(5):521-529. PubMed ID: 38336481
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic characteristic features of triple negative and nontriple negative breast cancer at a tertiary care hospital.
Mohapatra M
J Cancer Res Ther; 2023; 19(5):1186-1193. PubMed ID: 37787282
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Retraction Clefts in Chinese Invasive Breast Cancer Patients.
Huang L; Li Y; Du J; Li H; Lu M; Wang Y; Zhou W; Wang W; Wu H
Pathol Oncol Res; 2021; 27():1609743. PubMed ID: 34257612
[TBL] [Abstract][Full Text] [Related]
9. Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma.
Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
[TBL] [Abstract][Full Text] [Related]
10. Effects of clinicopathological factors on prognosis of young patients with resected breast cancer.
Li W; Deng Y; Wu Q; Chen W; Liu Z; Wang T; Ai C; Chen F; Wang Z; Ma G; Zhou Q
Medicine (Baltimore); 2021 Feb; 100(5):e23693. PubMed ID: 33592828
[TBL] [Abstract][Full Text] [Related]
11. Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers.
Lester TR; Hunt KK; Nayeemuddin KM; Bassett RL; Gonzalez-Angulo AM; Feig BW; Huo L; Rourke LL; Davis WG; Valero V; Gilcrease MZ
Breast Cancer Res Treat; 2012 Jan; 131(1):41-8. PubMed ID: 21331622
[TBL] [Abstract][Full Text] [Related]
12. The Bcl-2 protein: a prognostic indicator strongly related to ER and PR in breast cancer.
Bilalović N; Vranić S; Hasanagić S; Basić H; Tatarević A; Beslija S; Selak I
Bosn J Basic Med Sci; 2004 Oct; 4(4):5-12. PubMed ID: 15628988
[TBL] [Abstract][Full Text] [Related]
13. Extending Adjuvant Endocrine Therapy in Breast Cancer: Who, What, Why?
Vinayak S; Davidson NE
Oncology (Williston Park); 2019 Jun; 33(6):243-6. PubMed ID: 31219612
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Histone Deacetylase 3 (HDAC3) and Breast Cancer.
Cui Z; Xie M; Wu Z; Shi Y
Med Sci Monit; 2018 Apr; 24():2456-2464. PubMed ID: 29680858
[TBL] [Abstract][Full Text] [Related]
15. Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature.
Emad A; Ray T; Jensen TW; Parat M; Natrajan R; Sinha S; Ray PS
Breast Cancer Res; 2020 Jul; 22(1):74. PubMed ID: 32641077
[TBL] [Abstract][Full Text] [Related]
16. Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients.
Herrera AC; Panis C; Victorino VJ; Campos FC; Colado-Simão AN; Cecchini AL; Cecchini R
Cancer Immunol Immunother; 2012 Nov; 61(11):2193-201. PubMed ID: 22618884
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognosis of postpartum breast cancer.
Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
[TBL] [Abstract][Full Text] [Related]
18. The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.
Nakopoulou L; Lazaris AC; Panayotopoulou EG; Giannopoulou I; Givalos N; Markaki S; Keramopoulos A
J Clin Pathol; 2004 May; 57(5):523-8. PubMed ID: 15113861
[TBL] [Abstract][Full Text] [Related]
19. Clinical and epidemiologic profile of breast cancer in Tanzania.
Burson AM; Soliman AS; Ngoma TA; Mwaiselage J; Ogweyo P; Eissa MS; Dey S; Merajver SD
Breast Dis; 2010; 31(1):33-41. PubMed ID: 21109721
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factor analysis and clinical significance of HER‑2‑positive breast cancers with negative lymph nodes and a tumor diameter ≤1 cm.
Yan S; Wang Y; Guo Y; Zhang Y; Peng H; Tang H; Luo Y; Zhang A; Gao H
Oncol Lett; 2023 Nov; 26(5):491. PubMed ID: 37854866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
